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ABSTRACT
Background We have conducted a population-based
study of pleural mesothelioma patients with occupational
histories and measured asbestos lung burdens in
occupationally exposed workers and in the general
population. The relationship between lung burden and
risk, particularly at environmental exposure levels, will
enable future mesothelioma rates in people born after
1965 who never installed asbestos to be predicted from
their asbestos lung burdens.
Methods Following personal interview asbestos ﬁbres
longer than 5 mm were counted by transmission electron
microscopy in lung samples obtained from 133 patients
with mesothelioma and 262 patients with lung cancer.
ORs for mesothelioma were converted to lifetime risks.
Results Lifetime mesothelioma risk is approximately
0.02% per 1000 amphibole ﬁbres per gram of dry lung
tissue over a more than 100-fold range, from 1 to 4 in
the most heavily exposed building workers to less than 1
in 500 in most of the population. The asbestos ﬁbres
counted were amosite (75%), crocidolite (18%), other
amphiboles (5%) and chrysotile (2%).
Conclusions The approximate linearity of the dose–
response together with lung burden measurements in
younger people will provide reasonably reliable
predictions of future mesothelioma rates in those born
since 1965 whose risks cannot yet be seen in national
rates. Burdens in those born more recently will indicate
the continuing occupational and environmental hazards
under current asbestos control regulations. Our results
conﬁrm the major contribution of amosite to UK
mesothelioma incidence and the substantial contribution
of non-occupational exposure, particularly in women.
BACKGROUND AND AIMS
A large amount of asbestos remains in many older
buildings and there is continuing concern about
environmental exposure to occupants and occupa-
tional exposure during maintenance, renovation
and demolition in homes, schools and workplaces.
The resulting mesothelioma risks cannot be calcu-
lated by extrapolation from historical occupational
cohort studies because lifetime average airborne
exposure levels in the breathing zone cannot be esti-
mated even approximately either for the general
public or for plumbers, electricians and other build-
ing or demolition workers. Asbestos lung burden is
the only indicator of cumulative lifetime exposure
that can be measured reliably in a population-based
study. We have therefore developed a dose–response
model in a population-based series of mesothelioma
and resected lung cancer patients with occupational
histories obtained by personal interview and mea-
sured lung burdens. This will enable future meso-
thelioma rates to be predicted from lung burdens in
occupational groups and in the general population
for people born after 1965 who began work after
1980 when asbestos use had virtually ceased in
Britain (ﬁgure 1).
METHODS
Source of samples
The methods and results of the MALCS case–
control study have been described elsewhere.1
Telephone interviews on lifetime occupational2
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What this paper adds
▸ Britons born before the 1960s have the highest
mesothelioma death-rate worldwide, reﬂecting
high occupational asbestos exposure in men
and widespread environmental exposure in
both sexes before 1980, when asbestos use
virtually ceased in Britain.
▸ The risk to younger people from asbestos still
present in many buildings is not known but
could be substantial.
▸ We have shown that lifetime mesothelioma risk
is approximately 0.020% per 1000 asbestos
ﬁbres per gram of dry lung tissue over a more
than 100-fold range, from 1 to 4 in the most
heavily exposed building workers to less than 1
in 500 in most of the population.
▸ This will enable the risk from current asbestos
exposure to be estimated in people born since
the 1970s for whom lung samples are available
(eg, resected lung cancer or pneumothorax
patients), both in occupations at potential risk
such as builders and teachers and in the
general population.
▸ Such data will provide a rational basis for
regulations on worker protection and asbestos
monitoring and abatement, and for predicting
UK mesothelioma rates over the next 50 years.
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history were conducted between 2001 and 2006 on 622
patients with mesothelioma and 1420 population controls. We
also interviewed 420 patients with resected lung cancer born
since 1940 for whom lung samples could be obtained as a
control group for lung burden analyses. Patients with lung
cancer and mesothelioma identiﬁed through chest physicians,
lung cancer nurse specialists and Hospital Episode Statistics
(HES) notiﬁcations were recruited from 170 hospitals through-
out Britain.1 2 Resected lung cancers provide the only adequate
national source of lung samples in people who can be identiﬁed
systematically, are available for interview and have an age distri-
bution similar to mesothelioma. Only a small proportion of all
lung cancers are caused by asbestos, so the asbestos lung
burdens of this national sample are reasonably representative of
the general population except for a few per cent with very high
burdens. Written informed consent was obtained from 346
(77%) patients with mesothelioma and their next of kin for
postmortem samples to be analysed and from 406 (96%)
patients with lung cancer for analysis of resected tissue.
Transmission electron microscopy (TEM) analysis was per-
formed on samples as they became available, and 133 mesotheli-
oma samples and 262 lung cancer samples were analysed. All
were born since 1940 except 11 female mesotheliomas born
1925–1939. The study was approved by South Thames
Multicentre Research Ethics Committee.
Occupational classiﬁcation
Job titles were assigned to Standard Occupational Classiﬁcation
1990 (SOC 90) and Standard Industrial Classiﬁcation 1992 (SIC
92) codes and grouped into main job categories. Proportional
mortality ratios based on all mesothelioma deaths in Britain aged
16–74 years between 1991 and 20003 provided the basis for
this categorisation.1 2 Subjects were assigned to the highest-ranking
occupation they had worked in irrespective of duration. Previously
reported ORs for these categories1 are shown in table 3.
Lung sample preparation and TEM
Lung samples were anonymised and sent to the Health and
Safety Laboratory (HSL) for TEM counting of asbestos ﬁbres
longer than 5 mm (appendix 2). The target analytical sensitivity,
0.01 mf/g (million ﬁbres per dry gram), was achieved in all but
2.8% of the samples (2/133 mesotheliomas, 9/262 lung cancers).
Sensitivity was increased to 0.003 mf/g for a subset of samples in
which ﬁve or fewer asbestos ﬁbres were originally counted.
Figure 1 (A) UK Asbestos imports
from 1950 to 2000.27–30 (B) US
Asbestos imports from 1956 to 2000.30
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Statistical methods
The analyses are described in appendix 1. The ﬁtted model esti-
mates and adjusts for the effect of using lung cancers as controls.
At low doses the mesothelioma:lung cancer OR will reﬂect the
true mesothelioma dose–response, but as lung burden increases
there is increasing downward curvature (solid line in ﬁgure 2)
due to the increasing proportion of lung cancers caused by asbes-
tos. This model was used to estimate the distribution of lung
burdens in British men born in 1945, and hence to calculate their
lifetime risks for mesothelioma and lung cancer as a function of
asbestos lung burden (see table 2 footnotes). Our mesothelioma
cases are well represented by this birth cohort, as their median
date of birth was September 1944. The 1945 birth cohort’s
future age-speciﬁc death-rates were estimated by unadjusted age
and birth cohort analysis of British male mesothelioma and lung
cancer death-rates in 5-year age-groups (35–39 to 85–89) and
periods (1990–1994 to 2005–2009). Our dose–response model
is linear, so predicted mesothelioma and excess lung cancer age-
speciﬁc death rates are both proportional to mean lung burden in
each lung burden category. The lifetime risk (probability of dying
by age 90) was calculated actuarially in each lung burden cat-
egory assuming current (2013) UK rates for all other causes of
death. These lifetime risks were standardised to the projected
probabilities of dying by age 90 for mesothelioma (0.86%) and
lung cancer (4.67%) of all British men born in 1945.
The main results are based on total asbestos ﬁbre burden irre-
spective of ﬁbre type. The mesothelioma risk per ﬁbre of cro-
cidolite relative to amosite was estimated by logistic regression,
ﬁtting the weighted sum of the amosite and crocidolite lung
burdens, ignoring other ﬁbre types (which constituted only 7%
of counted ﬁbres) and adjusting the crocidolite:amosite weight-
ing to give the best-ﬁtting model.
RESULTS
Dose–response for mesothelioma and lung cancer
Table 1 shows the distribution of asbestos lung burdens in
mesotheliomas and resected lung cancers. The estimated ORs
Figure 2 Mesothelioma ORs (95%
ﬂoating CIs) in men using resected
lung cancers as controls, and asbestos
lung burden: upper graph linear axes,
lower graph logarithmic axes. When
the lung cancer risk caused by
asbestos is ignored the ﬁt of the linear
model is signiﬁcantly worse (p=0.02;
dashed line).
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for males and females combined (last row) are adjusted for
period of birth (1940–1944, 1945–1949, 1950–1954 and 1955
+) and sex, although neither was signiﬁcant (p=0.6 for sex,
ptrend=0.5 for period of birth). There were too few women for
separate analysis, and further model-ﬁtting was conﬁned to
men. The reference group for the mesothelioma ORs in ﬁgure 2
and table 2 is the lowest lung burden category (<0.025 mf/g,
average 0.0092 mf/g).
In the ﬁtted model risks for both mesothelioma and excess
lung cancer are proportional to lung burden. The estimated
coefﬁcients from the ﬁtted model (solid line in ﬁgure 2) are
82.2 (95% CI 54.3 to 124.5) per mf/g for the OR for meso-
thelioma and 2.55 (95% CI 0.62 to 10.37) per mf/g for the
increase in the lung cancer RR. The corresponding projected
lifetime risks and SMRs in each lung burden category are shown
in table 2 for the cohort of British men whose central date of
Table 1 Distribution of asbestos lung burdens (million fibres longer than 5 mm per dry gram) in men and women
TEM asbestos lung burden in million fibres per dry gram (Average lung burden for lung cancers in brackets)*
Source of sample
0−
(0.0092)
0.025−
(0.0364)
0.05−
(0.0854)
0.2−
(0.2930)
0.5−
(0.7690)
≥1.0
(2.0829) Total
Males
Mesothelioma 18 (16.8%) 8 (7.5%) 33 (30.8%) 21 (19.6%) 15 (14.0%) 12 (11.2%) 107 (100%)
Lung cancer 105 (57.7%) 22 (12.1%) 41 (22.5%) 8 (4.4%) 4 (2.2%) 2 (1.1%) 182 (100%)
OR (95% CI) 1.00 (ref) 2.12 (0.82 to 5.49) 4.70 (2.38 to 9.25) 15.31 (5.89 to 39.8) 21.88 (6.52 to 73.4) 35.00 (7.22 to 169.6)
Females
Mesothelioma 13 (50.0%) 2 (7.7%) 7 (26.9%) 4 (15.4%) 26 (100%)
Lung cancer 62 (77.5%) 11 (13.8%) 6 (7.5%) 1 (1.3%) 80 (100%)
OR (95% CI) 1.00 (ref) 0.87 (0.17 to 4.39) 6.36 (1.89 to 21.44) 19.08 (1.97 to 184.91)
Both sexes†
Mesothelioma 26 8 38 23 15 12 122
Lung cancer 167 33 47 9 4 2 262
Adjusted OR (95% CI) 1.00 (ref) 1.51 (0.62 to 3.65) 4.81 (2.61,8.85) 13.91 (5.69 to 34.0) 21.52 (6.45 to 71.7) 30.70 (6.38 to 147.7)
†Data for both sexes combined exclude 11 female mesothelioma cases born 1925–1939: 5 (TEM <0.025), 2 (TEM 0.025-), 2 (TEM 0.05-), 2 (TEM 0.2-). ORs for both sexes combined
are adjusted for sex and year of birth (1940–1944, 1945–1949, 1950–1954).
*Mean lung burden of lung cancer samples in each category except the highest (≥1 mf/g). One lung cancer with 22.0 mf/g was recoded as 2.08 mf/g, the mean for the other lung
cancer and the 12 mesotheliomas ≥1 mf/g. The mean for samples ≥1 mf/g was also set as 2.08 mf/g. Retaining the original value has little effect on the fitted model but distorts the
lung burdens shown in table 3.
TEM, transmission electron microscopy.
Table 2 Observed distribution of asbestos lung burdens in male mesotheliomas and lung cancers, estimated distribution in the UK male
population (central cohort born 1945), and predicted lifetime risks for mesothelioma and lung cancer
TEM asbestos burden (million fibres ≥5 mm in length per dry gram)
0− 0.025− 0.05− 0.2− 0.5− ≥1.0 All men
Mean lung burden (mf/g)* 0.00918 0.0364 0.0854 0.293 0.769 2.08
Distribution of lung burdens in mesotheliomas and lung cancers (from table 1) and fitted OR model (solid
line in figure 2)
Mesotheliomas (mean lung burden 0.430 mf/g) 16.8% 7.5% 30.8% 19.6% 14.0% 11.2% 100%
Lung cancers (mean lung burden 0.082 mf/g) 57.7% 12.1% 22.5% 4.4% 2.2% 1.1% 100%
Mesothelioma/lung cancer OR
Observed 1.0 (ref) 2.12 4.70 15.31 21.88 35.00
Fitted† 0.74 2.74 5.76 13.79 21.35 27.13
Estimated distribution of lung burdens and resulting mesothelioma and lung cancer risks due to asbestos
in the UK male population born in 1945
Lifetime mesothelioma risk‡ 0.18% 0.72% 1.66% 5.45% 12.91% 26.99% 0.86%
Mesothelioma SMR§ 21 83 193 633 1501 3137 100
Lifetime lung cancer risk‡ 4.55% 4.83% 5.34% 7.41% 11.67% 20.64% 4.67%
Lifetime excess lung cancer risk‡ 0.10% 0.38% 0.89% 2.97% 7.22% 16.20% 0.47%
Lung cancer SMR¶ 97 103 114 159 250 442 100
UK population (estimated mean lung burden 0.047 mf/g)** 63.08% 12.38% 20.70% 2.82% 0.83% 0.19% 100%
*Mean lung burden of lung cancer samples in each category except the highest (≥1 mf/g). One lung cancer with 22.0 mf/g was recoded as 2.08 mf/g, the mean for the other lung
cancer and the 12 mesotheliomas ≥1 mf/g. The mean for samples ≥1 mf/g was also set as 2.08 mf/g. Retaining the original value has little effect on the fitted model but distorts the
lung burdens shown in table 3.
†Solid line in figure 2.
‡Actuarial calculation of probability of dying by age 90 from projected mesothelioma and lung cancer rates assuming national rates for other causes of death.
§Proportional to mean lung burden.
¶Proportional to 1+2.55× (mean lung burden).
**Proportional to number of lung cancers divided by lung cancer SMR.
TEM, transmission electron microscopy, SMR, Standardised Mortality Ratio.
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birth is the beginning of 1945. (The median date of birth of our
mesothelioma cases was September 1944.) The predicted life-
time excess risk for lung cancer due to asbestos (0.47%) is 55%
of that for mesothelioma (0.86%). Mesothelioma and excess
lung cancer risks in each category and overall are proportional
to mean lung burden under this linear model, which implies
a lifetime mesothelioma risk of 0.020% per 1000 asbestos
ﬁbres/g. The proportion of men with lung burdens exceeding
1 mf/g is 11.2% (12/107) in mesotheliomas, 1.1% (2/182) in
lung cancers and is estimated as 0.19% in the UK male popula-
tion. The estimated mean lung burden for the 1945 male birth
cohort is 0.047 mf/g.
Occupation and lung burden
Amosite and crocidolite lung burdens among male mesothelio-
mas are shown in ﬁgure 3 by occupational category as previously
deﬁned1 (highest lifetime category irrespective of duration).
Concentrations are generally higher for amosite than crocidolite.
The highest amosite levels are predominantly in carpenters,
while four of the ﬁve men with the highest crocidolite levels
reported exposure to sprayed crocidolite. Table 3A, B show
TEM results for males and females respectively by occupational
category. Mesothelioma ORs (from Rake et al1) and mean lung
burdens for each type of asbestos are also shown. Mean lung
burdens are higher for mesothelioma than for lung cancer
within each occupational category and increase with increasing
occupational OR. Only six (3.3%) of 182 lung cancers in men
and none of the mesotheliomas or lung cancers in women had
lung burdens above 0.5 mf/g. In contrast, 27 (25.2%) of the
male mesotheliomas were above 0.5 mf/g. All 27 had a high-risk
occupational history and 16 had worked as a carpenter,
plumber, electrician or decorator. Construction and medium risk
industrial workers with lung cancer had much lower lung
burdens, with 50 (61.7%) below 0.025 mf/g and only three
(3.7%) above 0.2 mf/g. No asbestos ﬁbres were detected in 4 of
the 14 male mesotheliomas with lung burdens <0.025 mf/g who
worked in high risk or construction jobs. These four men all
reported short or occasional asbestos exposure in their work.
Levels are much lower in women, with the highest concentra-
tions in those who reported domestic exposure (table 3B).
Effects of ﬁbre type and size
Figure 1 shows UK asbestos imports since 1954. Of the ﬁve
million tonnes imported over this period 89% was chrysotile,
9% amosite and 2% crocidolite. Crocidolite use had ended by
1970 and amosite by 1980. Chrysotile imports had fallen by
90% by 1990 and ended by 2000. Few of the asbestos ﬁbres
detected were chrysotile, which disappears from the lung with a
half-life of a few months.4 The majority of counted asbestos
ﬁbres were amosite (75%) or crocidolite (18%), with much
lower numbers for chrysotile (1.9%), tremolite (1%), anthophyl-
lite (2%), actinolite (0.6%) and uncharacterised amphiboles
(1.7%). Burdens of chrysotile and these other amphiboles were
correlated with the total ﬁbre burden and were too low for their
Table 3 TEM asbestos lung burdens (million asbestos fibres ≥5 mm in length per dry gram) by most hazardous occupation
Panel A: Males born since 1940
Highest occupational
exposure category
Asbestos lung burden (million fibres per dry gram) Meso OR vs
population
controls*
Mean asbestos lung burden (million fibres per dry gram)
0− 0.025− 0.05− 0.2− 0.5− ≥1.0 Total Amosite Crocidolite
Other
amphiboles Chrysotile All asbestos
Non-construction high-risk occupations
Mesothelioma 5 3 11 7 6 4 36 17.5 0.375 0.094 0.014 0.005 0.487
Lung cancer 15 1 9 1 3 0 29 0.100 0.013 0.003 0.005 0.121
Carpenters
Mesothelioma 1 2 5 3 7 5 23 34.2 0.811 0.021 0.016 0.003 0.852
Lung cancer 3 1 3 2 0 0 9 0.088 0.002 0.005 0.000 0.095
Plumbers, electricians and painter/decorators
Mesothelioma 5 3 10 8 2 2 30 15.9 0.148 0.074 0.004 0.002 0.228
Lung cancer 12 4 5 3 1 1 26 0.095 0.040 0.006 0.001 0.143
Other construction or other reported exposure
Mesothelioma 3 0 2 0 0 1 6 5.1 0.056 0.192 0.000 0.000 0.248
Lung cancer 28 3 13 1 45 0.027 0.004 0.002 0.002 0.036
Medium risk industrial
Mesothelioma 3 0 2 3 0 8 4.1 0.069 0.057 0.010 0.001 0.137
Lung cancer 22 5 7 1 0 1† 36 0.078† 0.015† 0.005 0.001 0.098†
Domestic exposure
Mesothelioma 0 0 2 2 2.1 0.035 0.060 0.000 0.000 0.094
Lung cancer 4 4 0 8 0.009 0.004 0.006 0.001 0.020
Low-risk occupations
Mesothelioma 1 0 1 2 1.0 (ref) 0.015 0.018 0.005 0.000 0.038
Lung cancer 21 4 4 29 0.010 0.003 0.007 0.002 0.021
Total
Mesothelioma 18 8 33 21 15 12 107 0.351 0.073 0.010 0.003 0.438
Lung cancer 105 22 41 8 4 2 182 0.058† 0.012† 0.004 0.002 0.077†
*Male mesothelioma ORs from the original case–control study.1
†One lung cancer with 22.0 mf/g was recoded as 2.08 mf/g (see table 2 footnote *).
Retaining the original value increases the mean fibre count in lung cancers to 0.555 for amosite, 0.091 for crocidolite and 0.651 for all asbestos in the medium risk group, and to 0.153
for amosite, 0.027 for crocidolite and 0.186 for all asbestos in all male lung cancers.
TEM, transmission electron microscopy.
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effect on risk to be estimated. Table 4 (see online supplementary
material) shows mesotheliomas and lung cancers classiﬁed by
amosite and crocidolite concentration, ignoring other ﬁbres.
A logistic model in which one crocidolite ﬁbre is equivalent to
1.3 (95% CI 0.4 to 3.3) amosite ﬁbres gave the best ﬁt.
Distributions of ﬁbre length were similar irrespective of
disease status, ﬁbre type or lung burden, the overall distribution
being 76.1% 5–10 mm, 21.2% 10–20 mm and 4.5% >20 mm.
Median widths were 0.09 mm (chrysotile), 0.17 mm (crocido-
lite), 0.30 mm (amosite), 0.49 mm (tremolite), 0.58 mm
(anthophyllite) and 0.61 mm (actinolite). No signiﬁcant associ-
ation was seen between disease status and ﬁbre dimension after
stratifying by ﬁbre type.
DISCUSSION
Dose–response
This is the ﬁrst study with occupational histories obtained by
personal interview and asbestos lung burdens measured by TEM
from a large population-based series of patients with mesotheli-
oma. Our ﬁtted model estimates and adjusts for the effect of
using lung cancers as controls. Table 2 shows that the effect is
small among the 96% of men whose lung burdens are less than
0.2 mf/g (lung cancer SMR <1.1) but implies that the majority
of lung cancers are caused by asbestos in the 1% of men whose
lung burdens are above 0.5 mf/g. As expected, mean lung
burdens are consistently higher for mesothelioma than for lung
cancer within each occupational category and increase with
increasing occupational OR. Our results conﬁrm that most
mesotheliomas are caused by asbestos even in those who never
worked in asbestos-related occupations. Larger numbers and
more sensitive TEM would be required to estimate the incidence
of spontaneous mesotheliomas unrelated to asbestos, which is
ignored in our modelling. The ORs in ﬁgure 2 are scaled to
make the observed OR unity in the lowest exposure group
(<0.025 mf/g). The ﬁtted value (solid line in ﬁgure 2) equals
0.74 in this group. This small and non-signiﬁcant difference cor-
responds to a lifetime spontaneous mesothelioma risk of about
1 per 2000, almost an order of magnitude greater than early
estimates of the spontaneous incidence in both sexes.5
Our estimates of lifetime excess risk due to asbestos in British
men born in 1945 are 0.86% for mesothelioma and 0.47% for
lung cancer, a ratio of excess lung cancer to mesothelioma of
0.55. Two independent sources also suggest that asbestos causes
more mesotheliomas than lung cancers in British men. An ana-
lysis of proportional mortality ratios for different occupational
groups concluded that the ratio of excess lung cancer to meso-
thelioma in British men is about 0.7.6 The ratio was 1.3 (1795
Table 3 Continued
Panel B: Females: lung cancer cases born since 1940 and mesothelioma cases born since 1925. (The 11 mesotheliomas in women born 1925–1939 are included
and also shown in brackets.)
Highest
occupational
exposure
category
Asbestos lung burden (million fibres per dry gram)
Meso OR vs
population
controls*
Mean asbestos lung burden (million fibres per dry gram)
0− 0.025− 0.05− 0.2− 0.5− ≥1.0 Total Amosite Crocidolite
Other
amphiboles Chrysotile
All
asbestos
High−risk occupations
Mesothelioma 1 (1) 1 (1) 0 0 2 (2) 4.8 0.025 0.000 0.000 0.000 0.025
Lung cancer 3 1 0 0 4 0.010 0.000 0.000 0.003 0.013
Medium risk industrial
Mesothelioma 5 (1) 1 (1) 1 0 7 (2) 2.4 0.004 0.027 0.003 0.000 0.034
Lung cancer 20 1 4 0 25 0.012 0.002 0.003 0.002 0.019
Domestic exposure
Mesothelioma 2 (2) 0 2 (1) 3 (1) 7 (4) 1.9 0.103 0.077 0.004 0.003 0.186
Lung cancer 13 6 0 1 20 0.018 0.006 0.002 0.001 0.027
Low-risk occupations
Mesothelioma 5 (1) 0 4 (1) 1 (1) 10 (3) 1.0 (ref) 0.067 0.017 0.001 0.003 0.087
Lung cancer 26 3 2 0 31 0.009 0.002 0.002 0.001 0.013
Total
Mesothelioma 13 (5) 2 (2) 7 (2) 4 (2) 26 (11) 0.056 0.034 0.002 0.002 0.095
Lung cancer 62 11 6 1 80 0.012 0.003 0.003 0.001 0.019
*Female mesothelioma ORs from the original case–control study.1
Figure 3 Amosite and crocidolite lung burdens and occupational
categories in male mesotheliomas. (Burdens >1 million ﬁbres/g
truncated to 1 mf/g).
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deaths, 965 expected for lung cancer and 639 mesothelioma
deaths) in men in the Great Britain Asbestos Workers prospect-
ive study, but adjustment for smoking reduced the estimate for
the general population to 0.7.7 The ratio would be substantially
higher in the earlier birth cohorts included in that study due to
their higher smoking-related lung cancer rates, so our estimate
of the ratio for the 1945 birth cohort (0.55) may be approxi-
mately correct despite the imprecision of the estimated increase
in lung cancer RR (2.55 per mf/g, 95% CI 0.62 to 10.37). The
lifetime lung cancer risk at a given asbestos lung burden will
continue to fall in later generations because they smoke less but
the lifetime mesothelioma risk will be higher because they will
live longer. The model used by Tan et al8 implies that mesotheli-
oma incidence in the 1945 male birth cohort will increase less
steeply with age than in earlier generations. That analysis
(updated to 2013) predicts that their lifetime mesothelioma risk
will be 0.72%. If this proves more accurate than our simple pro-
jection (0.86%) the mesothelioma risk per 1000 ﬁbre/g should
be reduced from 0.020% to 0.017%. The lifetime risk per 1000
f/g in women will be slightly greater due to their longer life
expectancy.
Linear dose–response is the most important assumption
underlying the risk estimates for mesothelioma in table 2, which
are constrained to match the predicted lifetime risk for the UK
male population born in 1945. The relationship between meso-
thelioma risk and lung burden of asbestos measured by TEM is
perhaps the only example of a major human carcinogen for
which the data span such a wide range of measured dose and
risk. Stomata in the parietal pleura where long ﬁbres congregate
may be the main site of carcinogenesis,9 but for ﬁbres of speci-
ﬁed dimension it seems reasonable to assume a linear relation-
ship between inhaled dose, ﬁbre concentration in pleural
stomata and our measurements in lung parenchyma. Linear
dose–response might therefore be expected if mesothelioma
were initiated by a single asbestos ﬁbre in a single cell, but
tumour progression may also involve dose-related local inﬂam-
matory processes.9 Doll and Peto10 observed a quadratic dose–
response for cigarette smoking and lung cancer indicating both
early and late effects in lung carcinogenesis and suggested that
the linear relationship seen in other studies reﬂected inaccurate
measurement of lifelong smoking rates. Our lifetime mesotheli-
oma risk estimate of 0.020% per 1000 asbestos ﬁbres/g provides
a reasonably reliable basis for predicting future mesothelioma
rates in birth cohorts born since 1965 from their average asbes-
tos lung burdens. For estimating the exposure level or lung
burden that would cause lifetime mesothelioma risks of the
order of 1 in 100 000, an order of magnitude less than the esti-
mated spontaneous rate5 and two orders of magnitude below
the range in our data, risk assessment conventions rather than
epidemiology must determine the basis of the extrapolation. We
did not include any peritoneal mesotheliomas, which are both
under- and over-diagnosed due to confusion with cancers of the
ovary and other abdominal sites.11 Peritoneal mesotheliomas
constitute less than 4% of all mesotheliomas in the UK, and if
the dose-response with amphibole exposure is quadratic13 the
proportion will be even less at lower dose levels.
Effects of amphiboles and chrysotile
Asbestos consumption per head since the 1950s was similar in
Britain and the US for chrysotile and crocidolite but amosite con-
sumption was about ﬁve times higher in Britain (ﬁgure 1). This
seems likely to explain the ﬁvefold greater mesothelioma death-
rate in Britain than in the USA among men born around 1945.1
UK crocidolite imports ceased by 1970, a decade earlier than
amosite imports, but some exposure continued. The median con-
centration of crocidolite ﬁbres was 0.009 mf/g in male mesotheli-
oma cases born 1940–1949, and was still 0.004 mf/g in those
born after 1950 who started work around or after the time that
crocidolite use ended. Our model suggests that the mesothelioma
risk per ﬁbre is approximately 1.3 (95% CI 0.4 to 3.3) times
higher for crocidolite than for amosite. The proportion of TEM
ﬁbres with width >0.2 mm and therefore observable by phase
contrast optical microscopy (PCOM) was 38% for crocidolite
and 75% for amosite. Our estimate of the risk per ﬁbre of cro-
cidolite relative to amosite is thus approximately doubled to give
2.6 (95% CI 0.8 to 6.6) for PCOM data, statistically consistent
with the estimate of ﬁve based on cohort studies with PCOM
ﬁbre counting of air samples.12
Other evidence shows that chrysotile causes a much lower
mesothelioma risk than amosite or crocidolite.12 13 The rapid
clearance of chrysotile from the lung with a half-life of a few
months3 explains its virtual absence in our samples, and implies
that we cannot estimate its effects except by noting that amphi-
bole lung burdens account very well for mesothelioma inci-
dence. Rasmuson et al14 reported a good correlation between
lung burden and estimated cumulative exposure for amphiboles
but not for chrysotile. The prolonged heavy chrysotile exposure
that occurred in some British factories before the 1932 Asbestos
Industry Regulations were introduced caused an Standardised
Mortality Ratio (SMR) of more than 10 for lung cancer in
chrysotile textile workers,15 but the contribution of chrysotile
to current UK lung cancer rates is not known and may be
impossible to ascertain.
Biopersistence of amphiboles
Earlier studies showing an approximately linear relationship
between amphibole lung burden and mesothelioma risk
reported higher lung burdens in cases and controls16–18 than we
observed. The half-life of amphiboles in the lung has been esti-
mated as about 6–10 years4 19–21 for crocidolite and perhaps
20 years for amosite.4 Comparison of the distributions of lung
burdens in this study and in an earlier study of 69 British men
who died of mesothelioma17 also suggests a longer half-life for
amosite. These men, like our cases, were all born since 1940,
and most died in 1994–1995, about 9 years before our cases.
The respective proportions of male mesotheliomas exceeding
0.1 mf/g in our data and in the earlier series were 42.1% and
46.4% for amosite and 11.2% and 29.0% for crocidolite (ﬁbres
>6 mm; JC McDonald and B Armstrong, personal communica-
tion). However, we have not attempted to adjust our data for
elimination, for two reasons. First, these men were born since
1940 and were exposed predominantly between 1960 and the
late 1970s when amosite exposure ended, so their average inter-
vals from exposure to lung sampling were similar. Second, our
lung samples were obtained more than 20 years after substantial
amphibole exposure had ceased. If as Tossavainen et al22
suggest, further clearance of long amphibole ﬁbres will be
minimal, further studies over the next decade should show a
similar dose–response. A higher proportion of inhaled ﬁbres
from more recent environmental exposure will be retained,
however, somewhat exaggerating mesothelioma risks predicted
from amphibole lung burdens in those born more recently.
Conversely, a residence time model in which earlier exposure
causes a higher lifetime risk and later exposure is discounted8
would imply higher dose-speciﬁc risks in younger people, par-
ticularly for environmental exposure which presumably began in
childhood.
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Environmental asbestos exposure
Our case–control analysis suggested that 14% of male and 62%
of female mesotheliomas were not attributable to occupational
or domestic asbestos exposure.1 Among men and women with
only low-risk occupations 6 of 12 mesotheliomas and 6 of the 60
lung cancers had lung burdens exceeding 0.05 mf/g (table 3).
Three of these six mesotheliomas and one of the six lung cancers
mentioned potential asbestos exposure at work (one occasionally
handling sealed asbestos waste, one using asbestos ironing boards
at work and two ofﬁce workers in companies handling building
materials). These potential exposures, which had not been classi-
ﬁed as substantial in coding these occupational histories, suggest
that approximately 25% (3/12) of mesotheliomas in apparently
low-risk occupations may be due to such work-related exposures.
CONCLUSION
Our results conﬁrm the major contribution of amosite to UK
mesothelioma incidence and the substantial contribution of non-
occupational asbestos exposure, particularly in women.1 The
overall distribution of asbestos lung burdens in British men born
in the 1940s and their resulting mesothelioma and lung cancer
risks are summarised in table 2. The lowest exposure category
(<0.025 mf/g) includes 17% of mesotheliomas and 63% of the
population, while 45% of mesotheliomas but only 4% of
the population are above 0.2 mf/g. The approximate linearity
of the dose–response together with lung burden measurements
in younger people will provide reasonably reliable predictions of
future mesothelioma rates in those born since 1965 whose risks
cannot yet be seen in national rates. Burdens in those born
more recently will indicate the continuing occupational and
environmental hazards under current asbestos control regula-
tions. Similar population-based studies with uniform TEM ﬁbre
counting methods in other countries, together with the inter-
national mesothelioma death-rates now available following the
introduction of ICD-10 with a separate cause of death code for
mesothelioma, would provide a worldwide perspective on
future mesothelioma rates and more precise estimates of the risk
per ﬁbre for different amphiboles. Local studies are needed to
estimate the risk per ﬁbre, lung burdens in younger people, and
hence the continuing environmental hazard from amphibole
contamination in areas such as Libby, Montana23 and from
other naturally occurring asbestiform ﬁbres such as erionite in
Turkey and elsewhere.24 The extent to which mesotheliomas in
chrysotile workers are due to tremolite contamination or previ-
ous amphibole exposure could also be tested.25 If most
mesotheliomas are due to amphibole exposures, the quantitative
relationship we have observed between amphibole lung burden
and mesothelioma risk should also be seen in the USA and in
Eastern European and South American countries where amphi-
boles are reported to have constituted a much lower proportion
of asbestos consumption than in the UK.
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APPENDIX 1: STATISTICAL METHODS
Linear dose–response model
In the ith lung burden category there are l(i) lung cancers with
mean asbestos lung burden d(i) and m(i) mesotheliomas. If
mesothelioma risk and excess lung cancer relative risk both
increase linearly with increasing lung burden, with slope b for
mesothelioma and k for lung cancer, the expected ratio of meso-
thelioma to lung cancer is proportional to [b·d(i)]/[1+k·d(i)].
The slopes b and k are estimated by maximum likelihood
from the log(odds), which are treated as independent with nor-
mally distributed error variances v(i)=1/m(i)+1/l(i). Thus
log ðoddsÞ ¼ log ½m(iÞ=lðiÞ
¼ log ðb  d(iÞÞ  log ð1þ k  d(iÞÞ þ constant
þ e ðe N(0, v(i)Þ: ð1Þ
The constant determines the scale of mesothelioma risk (odds,
OR, lifetime risk or SMR). The constant was set as the observed
value of log[m(1)/l(1)], the log(odds) in the lowest (reference)
exposure category, giving the solid line in ﬁgure 2. ORs for each
lung burden category, including the reference group, are shown
in ﬁgure 2 with ‘ﬂoating absolute risk’ CIs corresponding to the
log(odds) variances v(i).25 Taking group 1 as the reference group,
the usual deﬁnition of the OR in group i is (true odds in group i)/
(true odds in groups 1). The deﬁnition of the ﬂoating OR is (true
odds in group i)/(observed odds in group 1). The denominator,
the observed odds in group 1, is a known constant with zero vari-
ance so the error variance of log(ﬂoating OR) in category i
equals v(i), the variance of log(odds).
Distribution of lung burdens in the general population and
corresponding lifetime risks
In the ith lung burden category the number of lung cancers that
were not caused by asbestos is l(i)/(1+k·d(i)). We assume that the
general population have the same distribution of lung burdens as
these non-asbestos lung cancers, so the proportion p(i) in the ith
lung burden category among British men in the same birth
cohort (ie, born around 1945) is estimated in table 2 as:
p(i) ¼ [l(i)=(1þ k  d(i))]=
X
[l(i)=ð1þ k  d(i)Þ]:
The mean lung burden of men in this birth cohort is thus
∑p(i)·d(i). Their projected death-rates at each age for
mesothelioma and lung cancer were calculated by unadjusted
age and birth cohort analysis of British male mesothelioma
and lung cancer death-rates in 5-year age-groups (35–39 to
85–89) and periods (1990–1994 to 2005–2009). For men
with average lung burden d(i) these projected rates were
multiplied by M·d(i) for mesothelioma and L·(1+k·d(i)) for
lung cancer. Their lifetime risks (respective probabilities of
dying by age 90 of mesothelioma and lung cancer) were
then calculated actuarially, assuming current (2013) rates for
all other causes of death. The constants M and L were
adjusted to make the population averages of these lifetime
risks equal the overall population projections for lung cancer
(4.67%) and mesothelioma (0.86%).
Comparison of amosite and crocidolite
The effect of crocidolite relative to amosite was estimated in a
logistic model ﬁtting log(lung burden of amosite plus crocidolite)
as a continuous variable in which crocidolite ﬁbres were given a
weighting w. We ﬁxed the offset using the estimated lung burden
coefﬁcient k from the unweighted model to give nested models
and a likelihood-based CI for w. For the jth individual with
amosite lung burden aj and crocidolite lung burden cj
log (odds) ¼ log [b  (ajþw  cj)]þ offset
where offset=log[m(1)/l(1)]−log(1+k·dj).
APPENDIX 2: LUNG SAMPLE PREPARATION AND
TRANSMISSION ELECTRON MICROSCOPY
All lung tissue samples were sent to a pathology laboratory in
Leeds for an initial assessment of their suitability. Thin tissue
sections were microtomed from the waxed blocks for further
assessment, before the blocks were de-waxed in xylene and
washed in ether and microdissected to remove cancerous and
ﬁbrotic tissue. The samples were then anonymised and sent to
the Health and Safety Laboratory (HSL) for quantitative trans-
mission electron microscopy (TEM) analysis. At HSL a represen-
tative sample was taken from the tissue supplied and diced into
cubes (approximately 3 mm sides) and dried overnight in a
vacuum dessicator and then weighed to obtain the dry weight.
The tissue was then digested in bleach and aliquots ﬁltered onto
membrane ﬁlters. The ﬁlter with the largest aliquot was ashed
overnight under controlled conditions in a low temperature
asher to further remove organic material. The ashed residual
was resuspended in water and a range of aliquots ﬁltered onto
0.2 mm pore size polycarbonate ﬁlters. When dry, strips of the
ﬁnal ﬁlters were carbon coated and sections cut out and trans-
ferred onto 200 mesh nickel index grids. Several grids from
each ﬁlter were prepared by dissolving away the polycarbonate
on a ﬁlter paper soaked with a mixture of 20%
1,2-diaminoethane and 80% 1-methyl-2 -pyrrolidone. This left
a thin carbon ﬁlm with the entrapped particles supported on
the grid. New disposable containers and ﬁltration equipment
were used for each sample to avoid any cross-contamination and
a process blank was run with each batch of analyses.
The prepared TEM grids were analysed in a FEI CM12 TEM
equipped with an EDAX Inc beryllium window energy disper-
sive X-ray detector. Grid openings were step scanned on the
ﬂuorescent screen at 11k magniﬁcation to identify ﬁbres (parti-
cles with parallel sides and >3:1 aspect ratio) over 5 mm in
length. The length, width, type of diffraction pattern and quan-
titative weight percentage oxide composition from the energy
dispersive X-ray analysis were recorded for each asbestos ﬁbre
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found. Counting continued until at least 30 asbestos ﬁbres had
been identiﬁed, or until 0.1 mg of defatted dry lung had been
analysed, giving an analytical sensitivity of 0.01 mf/g (million
ﬁbres per dry gram). This sensitivity was not achieved in 2.8%
of the samples (2/133 mesotheliomas, 9/262 lung cancers), due
to samples with low ﬁbre concentrations but high amounts of
other inorganic particles that required lower ﬁlter loadings and
hence large areas of the ﬁlter to be analysed by TEM. The sen-
sitivity was increased threefold to 0.003 mf/g by later extend-
ing the TEM analysis on newer equipment for a selected
subgroup of samples which included 25 of 26 male and 7 of 8
female samples from patients with mesothelioma born in 1940
or later in which 5 or fewer asbestos ﬁbres were originally
counted.
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